1. Home
  2. KYMR vs HXL Comparison

KYMR vs HXL Comparison

Compare KYMR & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • HXL
  • Stock Information
  • Founded
  • KYMR 2015
  • HXL 1946
  • Country
  • KYMR United States
  • HXL United States
  • Employees
  • KYMR N/A
  • HXL N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • HXL Major Chemicals
  • Sector
  • KYMR Health Care
  • HXL Industrials
  • Exchange
  • KYMR Nasdaq
  • HXL Nasdaq
  • Market Cap
  • KYMR 4.3B
  • HXL 5.0B
  • IPO Year
  • KYMR 2020
  • HXL N/A
  • Fundamental
  • Price
  • KYMR $63.94
  • HXL $69.04
  • Analyst Decision
  • KYMR Strong Buy
  • HXL Buy
  • Analyst Count
  • KYMR 19
  • HXL 9
  • Target Price
  • KYMR $68.95
  • HXL $71.44
  • AVG Volume (30 Days)
  • KYMR 665.0K
  • HXL 1.3M
  • Earning Date
  • KYMR 11-04-2025
  • HXL 10-22-2025
  • Dividend Yield
  • KYMR N/A
  • HXL 0.98%
  • EPS Growth
  • KYMR N/A
  • HXL N/A
  • EPS
  • KYMR N/A
  • HXL 0.84
  • Revenue
  • KYMR $43,735,000.00
  • HXL $1,876,400,000.00
  • Revenue This Year
  • KYMR $60.88
  • HXL $0.21
  • Revenue Next Year
  • KYMR N/A
  • HXL $10.38
  • P/E Ratio
  • KYMR N/A
  • HXL $81.95
  • Revenue Growth
  • KYMR N/A
  • HXL N/A
  • 52 Week Low
  • KYMR $19.45
  • HXL $45.28
  • 52 Week High
  • KYMR $65.69
  • HXL $74.35
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 63.12
  • HXL 54.84
  • Support Level
  • KYMR $56.75
  • HXL $67.38
  • Resistance Level
  • KYMR $61.21
  • HXL $71.19
  • Average True Range (ATR)
  • KYMR 3.12
  • HXL 2.04
  • MACD
  • KYMR -0.01
  • HXL -0.42
  • Stochastic Oscillator
  • KYMR 83.30
  • HXL 26.77

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About HXL Hexcel Corporation

Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use in the commercial aerospace, defense, and high-performance automotive markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engines, and other components and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.

Share on Social Networks: